1.48
Pmv Pharmaceuticals Inc stock is traded at $1.48, with a volume of 221.78K.
It is up +0.68% in the last 24 hours and up +16.54% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.47
Open:
$1.48
24h Volume:
221.78K
Relative Volume:
0.79
Market Cap:
$78.43M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.48
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-2.63%
1M Performance:
+16.54%
6M Performance:
+4.96%
1Y Performance:
-3.27%
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PMVP
Pmv Pharmaceuticals Inc
|
1.48 | 82.40M | 0 | -51.47M | -47.50M | -1.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
May-13-24 | Initiated | Craig Hallum | Buy |
Apr-12-24 | Initiated | Jefferies | Buy |
Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
Aug-19-21 | Initiated | Oppenheimer | Perform |
Aug-02-21 | Initiated | Guggenheim | Buy |
Jul-29-21 | Initiated | H.C. Wainwright | Buy |
Oct-20-20 | Initiated | BofA Securities | Buy |
Oct-20-20 | Initiated | Cowen | Outperform |
Oct-20-20 | Initiated | Evercore ISI | Outperform |
Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
Visual analytics tools that track PMV Pharmaceuticals Inc. performance2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
RSI and MACD Indicate Shift in PMV Pharmaceuticals Inc. Sentiment2025 Volatility Report & Risk Adjusted Buy and Sell Alerts - beatles.ru
Multi asset correlation models including PMV Pharmaceuticals Inc.2025 Analyst Calls & Free Community Supported Trade Ideas - Newser
Building trade automation scripts for PMV Pharmaceuticals Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser
How to escape a deep drawdown in PMV Pharmaceuticals Inc.July 2025 Short Interest & Weekly Breakout Watchlists - Newser
Is it time to cut losses on PMV Pharmaceuticals Inc.July 2025 Momentum & Weekly Breakout Stock Alerts - Newser
What MACD signals say about PMV Pharmaceuticals Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser
Can technical indicators confirm PMV Pharmaceuticals Inc.’s reversalQuarterly Profit Summary & Consistent Growth Equity Picks - Newser
Risk vs reward if holding onto PMV Pharmaceuticals Inc.Trade Ideas & Detailed Earnings Play Alerts - Newser
How high can PMV Pharmaceuticals Inc. stock goQuarterly Profit Report & Daily Profit Focused Screening - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.Quarterly Investment Review & Safe Entry Trade Reports - Newser
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionQuarterly Profit Report & Advanced Swing Trade Entry Alerts - Newser
Using data filters to optimize entry into PMV Pharmaceuticals Inc.Buy Signal & Low Risk High Reward Ideas - Newser
PMV Pharmaceuticals Inc. recovery potential after sell offWeekly Trend Recap & Real-Time Volume Spike Alerts - Newser
Can you recover from losses in PMV Pharmaceuticals Inc.July 2025 Institutional & Safe Capital Investment Plans - Newser
Price action breakdown for PMV Pharmaceuticals Inc.2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
Earnings visualization tools for PMV Pharmaceuticals Inc.2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
What MACD and RSI say about PMV Pharmaceuticals Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser
Is PMV Pharmaceuticals Inc. a candidate for recovery playEarnings Growth Report & Smart Investment Allocation Insights - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsEarnings Recap Report & Smart Money Movement Tracker - Newser
Analyzing recovery setups for PMV Pharmaceuticals Inc. investorsJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - Newser
PMV Pharmaceuticals Inc. Tests 50 Day MA After Sharp DeclineAnalyst Upgrade & Weekly Watchlist for Consistent Profits - kangso.co.kr
Top chart patterns to watch in PMV Pharmaceuticals Inc.July 2025 Review & Daily Chart Pattern Signals - Newser
Should you hold or exit PMV Pharmaceuticals Inc. nowTrade Risk Summary & Weekly Top Gainers Trade List - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser
Technical signs of recovery in PMV Pharmaceuticals Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser
Is PMV Pharmaceuticals Inc. reversing from oversold territoryMarket Growth Review & Free Community Consensus Stock Picks - Newser
Short Term Charts Align With Long Term Uptrend in PMV Pharmaceuticals Inc.July 2025 Trends & Proven Capital Preservation Tips - beatles.ru
What analysts say about PMV Pharmaceuticals Inc. stock outlookQuarterly Market Review & Fast Gain Stock Trading Tips - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):